The Latest Breaking News from Protein

Scientists are discovering that some genetic sequences encode proteins that lack any obvious ancestors, what geneticists call orphan genes.

High levels of lipoprotein(a), a form of "bad" cholesterol, may raise the risk of cardiovascular disease in people with hypertension by 18-20 per cent, according to recent research that was published in the American Heart Association journal Hypertension. Read on for details:

In late 2020, a converted van appeared in central Glasgow. Inside were clean needles, sterilising equipment, mirrors, “sharps bins” for the disposal of syringes, and supplies of the overdose reversal drug naloxone. There were also boxes containing protein bars, tea, blankets and a defibrillator, as well as two chairs and…

Despite its unfavourable reputation as a health risk when its blood levels are too high, cholesterol is a crucial part of the membrane that surrounds every human cell. Read on for details:

There’s a culinary revolution happening in the United States. More than ever before, Americans expect their meals to not only be delicious, but sustainable and local too. They’re increasingly turning to seafood options as a nutritious and more environmentally friendly source of protein. While restaurants and markets that can meet…

Candy maker Mars makes a move to get a leg up on its competitors.

Wheat provides 19% of the calories and 21% of the protein consumed by humans globally. But a fungal disease called fusarium head blight (FHB), which can infect wheat crops and contaminate the grain with toxins, is on the rise.

Model Hailey Bieber rustled up some of her favourite breakfast treats during the first episode of What's In My Kitchen?, which launched on her YouTube channel on Wednesday evening

Kymera unveiled promising results for its skin-disease treatment on Wednesday, snagging interest from Sanofi and sending KYMR stock flying.

New tech allows the fragile HCV E1E2 protein to be photographed. Now, scientists can work towards a vaccine

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.